Delivery Order SPE2DB22D3016-SPE2DB24FBHL8

Award Date 9/20/24
Potential Completion Date 9/23/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of NovologⓇ 100 unit/mL FlexPen 3mL, a prescription medication. The contract has a ceiling value of $1,093.27 and an ultimate completion date of August 30, 2024. It is a firm-fixed-price delivery order contract. The contract is not set aside for a specific business type. AmerisourceBergen holds several Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of NovologR 100 Unit/mL FlexPen 3mL. The contract has a ceiling value of $1,320.85 and runs through December 29, 2023. It is a firm-fixed-price contract, with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also registered in the System for Award Management...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a medical product, to support federal healthcare programs. The contract has a ceiling value of $3,692.58 and runs through January 27, 2025. It is a Firm Fixed Price contract and does not have a set-aside designation, indicating open competition....
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of NovologTM 100 unit/mL Flexpen 3 mL. The contract has a ceiling value of $1,433.68 and a completion date of July 18, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a pharmaceutical product, with a ceiling value of $3,351.77. The contract is a firm fixed-price, non-set-aside contract with an ultimate completion date of May 20, 2025. Amerisourcebergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of NovologTM 100 Unit/mL FlexPen 3mL, a medical product used for diabetes management. The contract has a ceiling value of $1,548.00 and runs through November 30, 2023. It is a firm fixed-price delivery order contract with no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp is a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of NovologTM 100 unit/mL FlexPen 3mL, a prescription insulin medication. The fixed-price, firm-fixed-price contract has a ceiling value of $1,327.70 and an ultimate completion date of July 19, 2024. AmerisourceBergen, a major pharmaceutical distributor, was awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,267.81 firm fixed-price contract is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a medical product. The contract has an ultimate completion date of October 21, 2024 and was awarded on October 18, 2024. This delivery order is under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML. The contract has a ceiling value of $2,197.01 and is a firm fixed price delivery order type, with an ultimate completion date of June 11, 2025. The contract is not set aside and is an open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of NovologTM 100 unit/mL FlexPenTM 3mL, a pharmaceutical product. The contract has a ceiling value of $4,084.80 and a period of performance through March 27, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a larger indefinite delivery contract (IDC)...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FBHL8
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of NovologT 100 Unit/mL Flexpen 3mL, a pharmaceutical product. The award has a ceiling value of $1,656.72 and an ultimate completion date of September 23, 2024. The contract is a firm-fixed-price delivery order, and there is no set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, supporting various defense and civilian agencies. The company holds several Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued up to $999,999,999 and $750,000, respectively, for delivering a comprehensive range of medical commodities and prescription drugs to federal healthcare providers and programs.

Generated 12/20/24, 9:15 AM